| Ipsen Grants Menarini Exclusive European Licence Rights to Adenuric ... - Reuters |
|
|
ReutersAdditionally, Adenuric® can be prescribed without dose adjustment to patients suffering from mild to moderate renal impairment and might be an alternative ... read more |